Impact of Comorbid Psoriasis on the Efficacy of Ustekinumab and Mirikizumab in Inflammatory Bowel Disease: A Post-hoc Analysis of UNITI, SEAVUE, and LUCENT

Digestive Diseases and Sciences 2026

View at publisher
Authors: E Wong, Parambir S. Dulai, John K. Marshall, Vipul Jairath, Walter Reinisch, N Narula
DOI: 10.1007/s10620-026-09752-6
Cited by: 1
References: 18

Fields of Study & Subjects

Psoriasis: Treatment and Pathogenesis Inflammatory Bowel Disease Spondyloarthritis Studies and Treatments

Publication details

Journal / source
Digestive Diseases and Sciences
Publisher
Springer Science and Business Media LLC
Volume
71
Issue
7
Pages
3024–3030
Publication date
19 February 2026
Language
EN